Uel Leite is an experienced executive in the biopharmaceutical industry, currently serving as Executive Director at Amgen since November 2001, with various leadership roles including Operations Therapeutic Area Head for Biosimilars and Oncology. Uel has successfully led the commercialization of innovative therapies, notably Lumakras for lung cancer, and managed significant products like Neupogen and Neulasta. Uel's background includes overseeing global operations for Aranesp®, where responsibilities encompassed cross-functional teams and supply chain management, contributing to substantial revenue generation. Previous positions include roles in global network planning and product development, along with early career experience as a process engineer at Procter & Gamble. Uel holds an MBA from Pepperdine Graziadio Business School and a B.S. in Chemical Engineering from UCLA.
Org chart
Teams
Offices
Amgen
252 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
